Harmony biosciences holdings, inc.HRMY.US Overview

US StockHealthcare

(No presentation for HRMY)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

HRMY Overall Performance

HRMY AI Analysis & Strategy

HRMY Recent Performance

1.24%

Harmony biosciences holdings, inc.

0.81%

Avg of Sector

-1.14%

S&P500

HRMY PowerScanner

HRMY Key Information

HRMY Valuation Metrics

HRMY Earnings Table

HRMY Profile

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.